Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Hirschfeld

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Clinical Therapeutics|March 23, 2024
Commentary on Hey, Hunter, Muller et al. A Never-ending Story: Evaluating Evidence in Medicinal Product Decision MakingSteven Hirschfeld
Pediatric Blood & Cancer|July 6, 2004
The pediatric research equity act and oncologySteven Hirschfeld
Frontiers in Pediatrics|March 10, 2018
Introduction and Goals for the National Children's StudySteven Hirschfeld
Journal of Pediatric Hematology/Oncology|March 8, 2005
Pediatric patients and drug safetySteven Hirschfeld
Developmental Medicine and Child Neurology|June 19, 2015
A child is a child is a child? Paediatric terminology in a health contextSteven Hirschfeld
Cancer Treatment and Research|February 20, 2007
The role of the fDA in cancer clinical trialsSteven Hirschfeld
IRB|July 9, 2016
A Federated Model of IRB Review for Multisite Studies: A Report on the National Children's Study Federated IRB InitiativeJulia Slutsman, Steven Hirschfeld
Critical Reviews in Oncology/Hematology|May 15, 2002
Oncology drug development: United States Food and Drug Administration perspectiveSteven Hirschfeld, Richard Pazdur
Therapeutic Innovation & Regulatory Science|June 28, 2019
What Could the Future of Safety Monitoring Look Like?Steven Hirschfeld, Anne Zajicek
Handbook of Experimental Pharmacology|September 2, 2011
Pediatric regulatory initiativesSteven Hirschfeld, Agnes Saint-Raymond
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|March 23, 2024
Commentary on Hey, Hunter, Muller et al. A Never-ending Story: Evaluating Evidence in Medicinal Product Decision MakingSteven Hirschfeld
Pediatric Blood & Cancer|July 6, 2004
The pediatric research equity act and oncologySteven Hirschfeld
Frontiers in Pediatrics|March 10, 2018
Introduction and Goals for the National Children's StudySteven Hirschfeld
Journal of Pediatric Hematology/Oncology|March 8, 2005
Pediatric patients and drug safetySteven Hirschfeld
Developmental Medicine and Child Neurology|June 19, 2015
A child is a child is a child? Paediatric terminology in a health contextSteven Hirschfeld
Cancer Treatment and Research|February 20, 2007
The role of the fDA in cancer clinical trialsSteven Hirschfeld
IRB|July 9, 2016
A Federated Model of IRB Review for Multisite Studies: A Report on the National Children's Study Federated IRB InitiativeJulia Slutsman, Steven Hirschfeld
Critical Reviews in Oncology/Hematology|May 15, 2002
Oncology drug development: United States Food and Drug Administration perspectiveSteven Hirschfeld, Richard Pazdur
Therapeutic Innovation & Regulatory Science|June 28, 2019
What Could the Future of Safety Monitoring Look Like?Steven Hirschfeld, Anne Zajicek
Handbook of Experimental Pharmacology|September 2, 2011
Pediatric regulatory initiativesSteven Hirschfeld, Agnes Saint-Raymond
Pageof 5